1[1]Jemal A,Murray T,Ward E,et al.Cancer statistics 2005.CA Cancer J Clin,2005,55:10
2[2]Carney DN,Hansen HH.Non-small-cell lung cancer:Statement or progress? N Engl J Med,2000,343:1261
3[3]Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.N Engl J Med,2002,346:92
4[4]Folkman J.What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst,(Bethesda) 1990,82:4
5[5]Asahara T,Takahashi T,Masuda H,et al.VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.EMBO J,1999,18:3964
6[6]Li CY,Shah S,Huang Q,et al.Initial stages of tumor cell-induced angiogenesis:Evaluation via skin window chambers in rodent models.J Natl Cancer Inst (Bethesda),2000,92:143
7[7]Midgley R,Kerr D.Bevacizumab:Current status and future directions.Ann Oncol,2005,16:999
8[8]Rosen LS.Clinical experience with angiogenesis signaling inhibitors:Focus on vascular endothelial growth factor (VEGF) blockers.Cancer Control,2002,9 (Suppl2):36
9[9]Baillie R,Carlile J,Pendleton N,et al.Prognostic value of vascularity and vascular endothelial growth factor expression in non-small-cell lung cancer.J Clin Pathol,2001,54:116
10[10]Han H,Silveman JF,Santucci TS,et al.Vascular endothelial growth factor expression in stage I non-small-cell lung cancer correlates with neoangiogenesis and a poor prognosis.Ann Surg Oncol,2001,8:72
5Schneider J. Tumor markers in detection of lung cancer [J] . Adv Clin Chem:2006,42:1-41.
6Gajra A, Lichtman SM. Treatment of advanced lung cancer in the elderly [J] . Hosp Pract (1995) , 2011, 39 (2) : 107-115.
7Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada [J] . J Natl Cancer Inst, 2000, 92 (3) : 205-216.
9Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J]. J Clin Oncol, 2004, 22 (9) : 1589-1597.
10Therasse P, Arbuck S G, Eisenhauer E A, et al. New guidelines to evaluate the response to treatment insolid tumors[J]. J Natl Cancer Inst, 2000,92 (3) : 205 - 216.
